About Infectious diseases notes
— United States, 2025. MMWR. January 16, 2025. 74(2):30-33. [Full Text]. Author David J Cennimo, MD, FAAP, FACP, FIDSA, AAHIVS Associate Professor of Medicine and Pediatrics, Adult and Pediatric Infectious Diseases, Rutgers New Jersey Medical SchoolDavid J Cennimo, MD, FAAP, FACP, FIDSA, AAHIVS is a member of the following medical societies: American Academy of HIV Medicine, American Academy of Pediatrics, American College of Physicians, American Medical Association, HIV Medicine Association, Infectious Diseases Society of America, Medical Society of New Jersey, Pediatric Infectious Diseases SocietyDisclosure: Nothing to disclose. Coauthor(s) Scott J Bergman, PharmD, FCCP, FIDSA, BCPS, BCIDP Antimicrobial Stewardship Program Coordinator, Infectious Diseases Pharmacy Residency Program Director, Department of Pharmaceutical and Nutrition Care, Division of Infectious Diseases, Nebraska Medicine; Clinical Associate Professor, Department of Pharmacy Practice, College of Pharmacy, University of Nebraska Medical Center Scott J Bergman, PharmD, FCCP, FIDSA, BCPS, BCIDP is a member of the following medical societies: American Association of Colleges of Pharmacy, American College of Clinical Pharmacy, American Pharmacists Association, American Society for Microbiology, American Society of Health-System Pharmacists, Infectious Diseases Society of America, Society of Infectious Diseases PharmacistsDisclosure: Received research grant from: Merck & Co., Inc. Specialty Editor Board Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug ReferenceDisclosure: Nothing to disclose. Chief Editor
Key features of the Infectious diseases notes that are enabled through these drivers include:
- Infectious Disease (Notes Practice Questions) - Examples
- Lecture Notes: Infectious Diseases, 6th Edition
- Lecture Notes Infectious Diseases - Washington Trails
- BIO- Infectious diseases notes.docx.pdf - BIO Notes
- (PDF) Lecture Notes on Infectious Diseases - ResearchGate
- Infectious Diseases Overview: Pathophysiology Highlights Notes
- Infectious Diseases NOTES - ppt download - slideplayer.com
ICD-10-CM Codes › J00-J99 › J00-J06 › J06- › 2025 ICD-10-CM Diagnosis Code J06.9 2025 ICD-10-CM Diagnosis Code J06.9 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Billable/Specific Code J06.9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2025 edition of ICD-10-CM J06.9 became effective on October 1, 2024. This is the American ICD-10-CM version of J06.9 - other international versions of ICD-10 J06.9 may differ.Applicable ToUpper respiratory disease, acuteUpper respiratory infection NOSUse AdditionalUse Additional HelpCertain conditions have both an underlying etiology and multiple body system manifestations due to the underlying etiology. For such conditions the ICD-10-CM has a coding convention that requires the underlying condition be sequenced first followed by the manifestation. Wherever such a combination exists there is a "use additional code" note at the etiology code, and a "code first" note at the manifestation code. These instructional notes indicate the proper sequencing order of the codes, etiology followed by manifestation. In most cases the manifestation codes will have in the code title, "in diseases classified elsewhere." Codes with this title are a component of the etiology/manifestation convention. The code title indicates that it is a manifestation code. "In diseases classified elsewhere" codes are never permitted to be used as first listed or principle diagnosis codes. They must be used in conjunction with an underlying condition code and they must be listed following the underlying condition.code (B95-B97 ICD-10-CM Range B95-B97Bacterial and viral infectious agentsNoteThese categories are provided for use as supplementary or additional codes to identify the infectious agent(s) in diseases classified elsewhere.B95 Streptococcus, Staphylococcus, and Enter...B96 Other bacterial agents as the cause of d...B97 Viral agents as the cause of diseases cl...) to identify infectious agent, if known, such as:respiratory syncytial virus (RSV) (ICD-10-CM Diagnosis Code B97.4Respiratory syncytial virus as the cause of diseases classified elsewhere2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Billable/Specific Code Applicable ToRSV as the cause of diseases classified elsewhereCode Firstrelated disorders, such as:otitis media (H65.-)upper respiratory infection (J06.9)Type 1 Excludesacute bronchiolitis due to respiratory syncytial virus (RSV) (J21.0)acute bronchitis due to respiratory syncytial virus (RSV) (J20.5)respiratory syncytial virus (RSV) pneumonia (J12.1)B97.4) The following code(s) above J06.9 contain annotation back-referencesAnnotation Back-ReferencesIn this context, annotation back-references refer to codes that contain:Applicable To annotations, orCode Also annotations, orCode First annotations, orExcludes1 annotations, orExcludes2 annotations, orIncludes annotations, orNote annotations, orUse Additional annotations that may be applicable to J06.9: J00-J99 2025 ICD-10-CM Range J00-J99Diseases of the respiratory systemNoteWhen a respiratory condition is described as occurring in more than one site and is not specifically indexed, it should be classified to the lower anatomic site (e.g. tracheobronchitis to bronchitis in J40).Type 2 Excludescertain conditions originating in the perinatal period (P04-P96)certain infectious and parasitic diseases (A00-B99)complications of pregnancy, childbirth and the puerperium (O00-O9A)congenital malformations, deformations and chromosomal abnormalities (Q00-Q99)endocrine, nutritional and metabolic diseases (E00-E88)injury, poisoning and certain other consequences of external causes (S00-T88)neoplasms (C00-D49)smoke inhalation (T59.81-)symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
